Medicare Enrolled
Dr. Adam Rosenbluth, MD
Cardiovascular Disease · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rosenbluth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenbluth?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rosenbluth
Dr. Adam Rosenbluth is a cardiovascular disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rosenbluth performed 5,677 Medicare services across 3,420 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rosenbluth received a total of $1,219,089 from 60 pharmaceutical and/or device companies across 2369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rosenbluth is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in NY
$1,219,089 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,677
Medicare services
Top 9% in NY for cardiovascular disease
3,420
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~299 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,197 | $146 | $220 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
817 | $5 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
692 | $106 | $180 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
654 | $12 | $22 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
550 | $2 | $5 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
326 | $31 | $65 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
287 | $10 | $25 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
274 | $4 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $76 | $130 |
| Ultrasound of leg arteries at rest and after exercise This test uses sound waves to create images of the blood vessels in the legs while the patient is resting and after physical activity to assess blood flow. |
123 | $148 | $216 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
88 | $72 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
88 | $35 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
83 | $181 | $350 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $106 | $160 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
47 | $18 | $26 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
46 | $185 | $450 |
| New patient office visit, complex (60-74 min) | 37 | $178 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $11 | $100 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
22 | $170 | $350 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
13 | $76 | $140 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $154 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
3.2% medium
95.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,219,089
Total received (2018-2024)
Avg $174,156/year across 7 years
Top 0% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
2,369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,198,976 (98.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,592 (1.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,521 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$124,213
2023
$151,195
2022
$207,596
2021
$127,927
2020
$153,285
2019
$253,861
2018
$201,012
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$71,612
Boehringer Ingelheim Pharmaceuticals, Inc.
$22,817
Lilly USA, LLC
$16,980
Boston Scientific Corporation
$10,112
Intra-Sana Laboratories
$304
Xeris Pharmaceuticals, Inc.
$270
AstraZeneca Pharmaceuticals LP
$268
Novartis Pharmaceuticals Corporation
$253
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$208
HEARTFLOW, INC.
$196
Amgen Inc.
$192
ABBVIE INC.
$187
PFIZER INC.
$163
GlaxoSmithKline, LLC.
$145
IDORSIA PHARMACEUTICALS US INC
$125
Takeda Pharmaceuticals U.S.A., Inc.
$94
Philips North America LLC
$56
Merck Sharp & Dohme LLC
$49
Antares Pharma, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$43
E.R. Squibb & Sons, L.L.C.
$30
Ardelyx, Inc.
$19
Janssen Pharmaceuticals, Inc
$17
Phathom Pharmaceuticals, Inc.
$15
Seqirus USA Inc
$14
Top 3 companies account for 89.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$491,879
Boehringer Ingelheim Pharmaceuticals, Inc.
$257,780
Novo Nordisk Inc
$225,171
Boston Scientific Corporation
$82,105
Lilly USA, LLC
$69,878
SANOFI-AVENTIS U.S. LLC
$42,545
BOSTON SCIENTIFIC CORPORATION
$26,532
Novartis Pharmaceuticals Corporation
$13,166
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,576
Janssen Pharmaceuticals, Inc
$1,059
PFIZER INC.
$899
Amgen Inc.
$701
GlaxoSmithKline, LLC.
$697
Takeda Pharmaceuticals U.S.A., Inc.
$516
Intra-Sana Laboratories
$444
E.R. Squibb & Sons, L.L.C.
$282
IDORSIA PHARMACEUTICALS US INC
$277
Xeris Pharmaceuticals, Inc.
$270
Amarin Pharma Inc.
$255
AbbVie Inc.
$229
Eisai Inc.
$227
Merck Sharp & Dohme Corporation
$211
ABBVIE INC.
$210
HEARTFLOW, INC.
$196
Bayer Healthcare Pharmaceuticals Inc.
$187
Lundbeck LLC
$178
Abbott Laboratories
$149
Regeneron Healthcare Solutions, Inc.
$123
Baxter Healthcare
$118
Bayer HealthCare Pharmaceuticals Inc.
$116
Merck Sharp & Dohme LLC
$108
Astellas Pharma US Inc
$94
Currax Pharmaceuticals LLC
$89
Biohaven Pharmaceuticals, Inc.
$63
Antares Pharma, Inc.
$61
Philips North America LLC
$56
Genentech USA, Inc.
$53
EISAI INC.
$52
Allergan Inc.
$52
Althera Pharmaceuticals LLC
$50
Kowa Pharmaceuticals America, Inc.
$49
Orexigen Therapeutics, Inc.
$45
Esperion Therapeutics, Inc.
$34
Ironwood Pharmaceuticals, Inc
$29
Supernus Pharmaceuticals, Inc.
$26
IRONWOOD PHARMACEUTICALS, INC
$25
Medtronic Vascular, Inc.
$23
SCPHARMACEUTICALS INC.
$22
VIVUS LLC
$20
Ardelyx, Inc.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$18
Noden Pharma USA Inc
$17
DEXCOM, INC.
$16
Phathom Pharmaceuticals, Inc.
$15
Seqirus USA Inc
$14
SANOFI PASTEUR INC.
$14
Coloplast Corp
$13
Teva Pharmaceuticals USA, Inc.
$13
Hikma Pharmaceuticals USA
$11
Eyevance Pharmaceuticals LLC
$11
Top 3 companies account for 80.0% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · AIRSUPRA · AJOVY · AREXVY · Adempas · Amitiza · BELSOMRA · BREZTRI · BRILINTA · BYDUREON · BYSTOLIC · Belviq · CAMZYOS · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · CREON · Corlanor · DEXCOM G6 TRANSMITTER · Dayvigo · ELIQUIS · ENTRESTO · Entyvio · FARXIGA · FFRct · FLUZONE QUADRIVALENT · FUROSCIX · Fluad · GENERAL THERAPIES · GENERAL THERAPIES · GILENYA · GVOKE HYPOPEN · Hillrom - Carnation Ambulatory Monitor · IBSRELA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LYRICA · Levemir · Linzess · Livalo · MITRACLIP · MOTEGRITY · MOUNJARO · MULTAQ · MYRBETRIQ · Mitigare · NEXLETOL · NOCDURNA · NORTHERA · NURTEC ODT · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QSYMIA · QUVIVIQ · RELTONE 200 MG · RYBELSUS · Repatha · Reveal LINQ · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SPEEDICATH · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TEKTURNA · THERAPIES · TLANDO · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tobradex ST · Tresiba · Trintellix · UBRELVY · Uloric · VERQUVO · VIAGRA · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Watchman · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XIGDUO · XYOSTED · Xofluza · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in NY.
Geographic Context
Cardiologists within 10 mi
1,852
Per 100K population
113.8
County median income
$104,553
Nearest hospital
HOSPITAL FOR SPECIAL SURGERY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rosenbluth is a clinical cardiology specialist, with above-average Medicare volume (top 9% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rosenbluth experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Rosenbluth performed 1,197 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenbluth receive payments from pharmaceutical companies?
Yes. Dr. Rosenbluth received a total of $1,219,089 from 60 companies across 2,369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenbluth's costs compare to other cardiologists in New York?
Dr. Rosenbluth's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenbluth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New York
Browse cardiologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology